NCT01137916View on ClinicalTrials.gov

Study to Evaluate Imatinib in Desmoid Tumors

PHASE2CompletedINTERVENTIONAL

Enrollment

39

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions

Aggressive FibromatosisDesmoid Tumor

Interventions

DRUG

Imatinib

800 mg

Trial Locations (1)

68167

University of Heidelberg, Mannheim University Medical Center, Mannheim

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Novartis

INDUSTRY

lead

Heidelberg University

OTHER